Skip to main content
Figure 2 | Critical Care

Figure 2

From: Levosimendan attenuates multiple organ injury and improves survival in peritonitis-induced septic shock: studies in a rat model

Figure 2

Progress of plasma (A) nitric oxide (NO) and (B) interleukin-1β (IL-1β) levels during the experimental period. Depicted are the changes of plasma NO and IL-1β levels in different groups of sham operation (SOP, n = 10), SOP plus Levosimendan administration (SOP + LS, n = 6), cecal ligation and puncture (CLP, n = 10), CLP plus vehicle treatment (CLP + Veh, n = 6) and CLP plus Levosimendan administration (CLP + LS, n = 12). Data are expressed as mean ± standard error of the mean. *P <0.05, all groups versus SOP; †P <0.05, CLP + LS versus CLP + Veh.

Back to article page

Critical Care

ISSN: 1364-8535